Siemens Healthineers Cuts 2026 Outlook As China Diagnostics Resets

Novo NordiskNovo Nordisk faces competition from Canada compounders - medwatch.com

Endpoints NewsAngelini fortifies neurology portfolio with $4.1B buyout of Catalyst Pharma

Eli LillyPharma Pulse: GLP-1 Momentum Builds While Lilly Expands Genetic Medicine Manufacturing - Pharmaceutical Commerce

Siemens HealthineersWeak Diagnostics segment weighs heavily on Siemens Healthineers - marketscreener.com

LabiotechMaking labs smarter for scientific breakthroughs

Siemens HealthineersEarnings call transcript: Siemens Healthineers Q2 2026 sees stock plunge amid Diagnostics woes - Investing.com

ModernaKorea University and Moderna have been working on mRNA hantavirus vaccine since 2023 - Brussels Signal

Science Daily BiotechScientists accidentally discover DNA that breaks the rules of life

Samsung BiologicsSamsung fund invests in Cartography, adding another cancer biotech to portfolio - koreabiomed.com

Siemens HealthineersSiemens Healthineers Cuts 2026 Outlook As China Diagnostics Resets - Finimize

10x Genomics NewsUS-based 10x Genomics establishes first dedicated R&D lab in Singapore - BioSpectrum Asia